Lithium induces gene expression through lymphoid enhancer-binding factor/T-cell factor responsive element in rat PC12...

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Lithium inhibits glycogen synthase kinase-3 (GSK-3), increasing cytoplasmic beta-catenin.
• Activated beta-catenin can interact with lymphoid enhancer-binding factor (LEF)/T-cell factor (TCF) transcription factors to induce gene expression in certain cell types.
• The effect of lithium on LEF/TCF-mediated gene expression in neuronal cells remains uninvestigated.

Purpose of the Study:

• To investigate the effects of lithium on LEF/TCF-mediated gene expression in cells with a neuronal phenotype.
• To construct and utilize a LEF/TCF-dependent luciferase reporter gene system for this investigation.

Main Methods:

• PC12 cells, a cell line with a neuronal phenotype, were transiently transfected with a LEF/TCF-dependent luciferase reporter gene.
• The transfected cells were treated with lithium.
• Luciferase activity was measured to assess the impact of lithium on LEF/TCF-mediated transcription.

Main Results:

• Lithium treatment induced a time-dependent increase in LEF/TCF-mediated luciferase activity in PC12 cells.
• This finding is consistent with the known inhibitory effect of lithium on GSK-3.
• This study provides the first evidence of lithium-induced gene expression mediated by a LEF/TCF responsive element in PC12 cells.

Conclusions:

• Lithium can modulate LEF/TCF-mediated gene expression in cells of neuronal origin (PC12 cells).
• The observed effect is linked to lithium's inhibition of GSK-3 and subsequent impact on the beta-catenin/LEF/TCF pathway.
• These findings open new avenues for understanding lithium's molecular mechanisms in neuronal contexts.